Bone-marrow transplantation (first of two parts).
D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000628:therapy; D000818:Animals; D001853:Bone Marrow / Q000276:immunology; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D004285:Dogs; D005260:Female; D006087:Graft vs Host Reaction / Q000517:prevention & control; D006098:Granulocytes; D000882:Haplorhini; D006648:Histocompatibility; D006650:Histocompatibility Testing; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000628:therapy; D007165:Immunosuppression Therapy; D017053:Infection Control; D007938:Leukemia / Q000628:therapy; D051379:Mice; D008875:Middle Aged; D011247:Pregnancy; D011830:Radiation Effects; D014019:Tissue Donors; D014184:Transplantation, Homologous / Q000379:methods; D014427:Twins
D003520:Cyclophosphamide